KU Leuven
kuleuven.beTotal trials
363
Active
53
Phase 3
9
Total enrollment
200,248,693
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Oliclinomel N71000 OR N71000E // Clinimix N17G35 OR N17G35E | — | — | — | — | — | 1 | |
| Insulin | — | — | — | — | — | 1 | |
| Cannabidiol or placebo | — | — | — | — | — | 1 |
Next readouts
- 2011-02
- 2022-11-30
- 2026-05-31
Top conditions
- Stroke19
- Chronic Obstructive Pulmonary Disease14
- Parkinson Disease13
- Healthy11
- Low Back Pain10
- Critical Illness9
- COPD7
- Breast Cancer6
Frequently asked questions about KU Leuven
- How many clinical trials does KU Leuven have on ClinicalTrials.gov?
- KU Leuven is listed as the lead sponsor on 363 clinical trials in ClinicalTrials.gov, 53 of which are currently active (recruiting, enrolling, or ongoing).
- How many of KU Leuven's trials are in Phase 3?
- 9 of KU Leuven's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does KU Leuven focus on?
- KU Leuven's most-studied conditions on ClinicalTrials.gov are Stroke, Chronic Obstructive Pulmonary Disease, Parkinson Disease, Healthy, Low Back Pain.
- When are KU Leuven's next clinical trial readouts?
- KU Leuven has 3 upcoming primary-completion readouts tracked here; the soonest is “Impact of Early Parenteral Nutrition Completing Enteral Nutrition in Adult Critically Ill Patients”, expected around 2011-02.